计算生物学
药物发现
抗病毒药物
药品
蛋白质水解
人类健康
生物
风险分析(工程)
计算机科学
医学
生物信息学
药理学
生物化学
环境卫生
酶
作者
Yang Zhou,Peng Zhan,Nerea López-Carrobles,Dang Ding,Xinyong Liu,Luis Menéndez‐Arias,Peng Zhan
出处
期刊:Acta Materia Medica
[Compuscript, Ltd.]
日期:2023-01-01
卷期号:2 (3)
被引量:1
标识
DOI:10.15212/amm-2023-0019
摘要
Viral infections represent a major threat to human health and the global economy; however, most of the currently available antiviral drugs are not fully effective in restricting viral replication and selecting for drug-resistant variants. Targeted protein degradation technologies are promising strategies to avoid or delay the emergence of drug resistance. Among the protein degradation-based multi-specific approaches, proteolysis targeting chimera (PROTAC) is the main strategy applied in the antiviral field. In this review we will introduce the elements and mechanisms of action used by PROTAC technology, as well as the advantages of PROTACs over available antiviral drugs. We also summarize the latest progress in the application of PROTACs in antiviral research, discuss existing challenges and look into future opportunities for antiviral drug discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI